• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基化DNA作为多种体液中肿瘤性疾病的一种可能的筛查标志物。

Methylated DNA as a possible screening marker for neoplastic disease in several body fluids.

作者信息

Müller Hannes M, Widschwendter Martin

机构信息

Department of Obstetrics and Gynecology, Innsbruck University Hospital, Austria.

出版信息

Expert Rev Mol Diagn. 2003 Jul;3(4):443-58. doi: 10.1586/14737159.3.4.443.

DOI:10.1586/14737159.3.4.443
PMID:12877384
Abstract

Early detection appears to be one of the most important approaches to reducing mortality caused by neoplasia. Changes in DNA methylation have been recognized as one of the most common molecular alterations in human tumors. Due to the ubiquity of DNA methylation changes and the possibility to detect methylated DNA in several body fluids, this specifically altered DNA may serve as a potential new screening marker for neoplastic disease.

摘要

早期检测似乎是降低肿瘤所致死亡率的最重要方法之一。DNA甲基化变化已被公认为人类肿瘤中最常见的分子改变之一。由于DNA甲基化变化普遍存在,且有可能在多种体液中检测到甲基化DNA,这种特异性改变的DNA可能成为肿瘤疾病潜在的新型筛查标志物。

相似文献

1
Methylated DNA as a possible screening marker for neoplastic disease in several body fluids.甲基化DNA作为多种体液中肿瘤性疾病的一种可能的筛查标志物。
Expert Rev Mol Diagn. 2003 Jul;3(4):443-58. doi: 10.1586/14737159.3.4.443.
2
Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease.用于疾病准确分类的结直肠肿瘤特异性甲基化标志物的鉴定与验证
Mol Cancer Res. 2007 Feb;5(2):153-63. doi: 10.1158/1541-7786.MCR-06-0034.
3
Circulating methylated DNA.循环甲基化DNA
Ann N Y Acad Sci. 2004 Jun;1022:33-9. doi: 10.1196/annals.1318.006.
4
Molecular detection of gene mutations and methylation abnormalities: applications in solid tumor diagnosis.基因突变和甲基化异常的分子检测:在实体瘤诊断中的应用
Expert Rev Mol Diagn. 2002 Mar;2(2):97-108. doi: 10.1586/14737159.2.2.97.
5
Molecular diagnostics: a new frontier in cancer prevention.分子诊断:癌症预防的新前沿。
Expert Rev Mol Diagn. 2004 Jul;4(4):503-11. doi: 10.1586/14737159.4.4.503.
6
Molecular diagnostic applications of DNA methylation technology.DNA甲基化技术的分子诊断应用
Clin Biochem. 2004 Jul;37(7):595-604. doi: 10.1016/j.clinbiochem.2004.05.010.
7
Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.在粪便DNA中检测未表达的波形蛋白基因的结肠癌特异性甲基化。
J Natl Cancer Inst. 2005 Aug 3;97(15):1124-32. doi: 10.1093/jnci/dji204.
8
The potential of molecular screening.
Surg Oncol Clin N Am. 1999 Oct;8(4):641-56, vi.
9
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.评估体液中启动子高甲基化检测作为头颈部鳞状细胞癌的筛查/诊断工具。
Clin Cancer Res. 2008 Jan 1;14(1):97-107. doi: 10.1158/1078-0432.CCR-07-0722.
10
[Contribution of molecular biology to new diagnostic and/or prognostic markers characterization in cancerogenesis].
Ann Biol Clin (Paris). 2007 Jan-Feb;65(1):21-6.

引用本文的文献

1
A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility.外周血 DNA 甲基化特征谱-panel 可能预测结直肠癌易感性。
BMC Cancer. 2020 Jul 25;20(1):692. doi: 10.1186/s12885-020-07194-5.
2
Nicotine attenuates global genomic DNA methylation by influencing DNMTs gene expression in human endometrial stromal cells.尼古丁通过影响人子宫内膜基质细胞中DNA甲基转移酶(DNMTs)的基因表达来减弱全基因组DNA甲基化。
Genes Environ. 2020 Feb 5;42:6. doi: 10.1186/s41021-020-0144-5. eCollection 2020.
3
Improved amplification efficiency on stool samples by addition of spermidine and its use for non-invasive detection of colorectal cancer.
通过添加亚精胺提高粪便样本的扩增效率及其在结直肠癌无创检测中的应用。
BMC Biotechnol. 2015 May 29;15:41. doi: 10.1186/s12896-015-0148-6.
4
FT-IR microspectrometry reveals the variation of membrane polarizability due to epigenomic effect on epithelial ovarian cancer.傅里叶变换红外光谱显微术揭示了表观基因组对上皮性卵巢癌的影响所导致的膜极化率变化。
Int J Mol Sci. 2014 Oct 8;15(10):17963-73. doi: 10.3390/ijms151017963.
5
DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.用于胃癌和结直肠癌无创检测的DNA甲基化和微小RNA生物标志物
Biochem Biophys Res Commun. 2014 Dec 5;455(1-2):43-57. doi: 10.1016/j.bbrc.2014.08.001. Epub 2014 Aug 13.
6
Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.NPY、PENK 和 WIF1 的异常甲基化作为一种有前途的基于血液的结直肠癌诊断标志物。
BMC Cancer. 2013 Dec 1;13:566. doi: 10.1186/1471-2407-13-566.
7
Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer.基于血液的结直肠癌检测的 DNA 甲基化生物标志物的全基因组发现。
PLoS One. 2012;7(11):e50266. doi: 10.1371/journal.pone.0050266. Epub 2012 Nov 28.
8
Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort.乳腺癌中甲基化基因:家族性乳腺癌队列中与临床和组织病理学特征的相关性。
Cancer Biol Ther. 2011 May 15;11(10):853-65. doi: 10.4161/cbt.11.10.15177.
9
Epigenetic Signatures in Breast Cancer: Clinical Perspective.乳腺癌中的表观遗传特征:临床视角
Breast Care (Basel). 2010;5(2):66-73. doi: 10.1159/000309138. Epub 2010 Apr 23.
10
Control of carry-over contamination for PCR-based DNA methylation quantification using bisulfite treated DNA.使用亚硫酸氢盐处理的DNA对基于PCR的DNA甲基化定量中的残留污染进行控制。
Nucleic Acids Res. 2007;35(1):e4. doi: 10.1093/nar/gkl955. Epub 2006 Nov 28.